TP53 and breast neoplasm: In a mutation study of 560 Malaysian breast tumors, compared with breast tumors in Caucasian women, they found that ER+ Asian breast tumors had a higher prevalence of TP53 somatic mutations and Asian women showed an increased prevalence of HER2-positive molecular subtypes (Pan et al., 2020).